secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2024-02-14T23:59:59+00:00
Accession:  0001104659-24-023641
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunome prices $200M follow-on offering of 10M shares at $20/share
-------------------------------------------------------------------

- Priced 10,000,000 common shares at $20.00 each; gross proceeds ~$200M before expenses.
- Underwriters have 30-day option to purchase up to 1,500,000 additional shares.
- Closing expected February 16, 2024, subject to customary conditions.
- Proceeds intended for general corporate purposes; J.P. Morgan, Cowen, Leerink, Guggenheim lead offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465924023641/0001104659-24-023641-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465924023641/tm246214d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-023641

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer